Data currency is a concept that most pharmaceutical organizations understand in theory but struggle to achieve in practice. Epidemiological estimates are commissioned, produced, and then recycled across strategy documents for years, regardless of whether the underlying disease landscape has changed. In a world where therapeutic categories evolve rapidly and patient populations are continuously...